Plain-English translation of NCT07169747 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether —a compound that affects how your brain processes emotions and thoughts—combined with professional psychological support, can help treat anorexia nervosa in young adults. Researchers believe this medication may help reduce the rigid thinking patterns and emotional challenges that keep eating disorders going. You would receive two doses of the medication about a month apart, along with therapy sessions before, during, and after treatment.
Anorexia nervosa is one of the most serious mental health conditions, and current treatments only help about half of patients recover within four years. Many people who do recover relapse within a few years. This trial exists because early research suggests this medication could help people think more flexibly and manage emotions better—two things that are especially difficult in eating disorders.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would be randomly assigned to either receive the new medication with psychological support or continue with your current treatment as usual. If you receive the medication, you would have preparation therapy sessions, then take two doses about four weeks apart, with support from trained staff during the experience and follow-up sessions afterward to help you integrate what you learn. You would visit the study site multiple times over about 6 months and may also be asked to complete brain scans and answer questions about your mood, thoughts, and eating behaviors.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Sweden